KINGSTON, Jamaica — In a significant stride toward enhancing public health, Biomedical Caledonia Medical Laboratory Limited has broadened the accessibility of National Health Fund (NHF) card services across all its islandwide locations. This expansion enables patients to avail themselves of subsidized pap smears, prostate-specific antigen (PSA) tests, and HbA1c diabetes monitoring, crucial for early detection and management of chronic conditions. The initiative includes the recently inaugurated Holborn Road facility in Kingston, ensuring comprehensive coverage across the island. CEO Helen Christian emphasized the importance of this development, stating, ‘Affordable diagnostic testing can significantly impact early detection versus late-stage diagnosis. Early detection saves lives, and we are dedicated to making these essential services accessible to every community we serve.’ The expansion was made possible through collaboration with the NHF and Advanced Integrated Systems (AIS), which facilitated streamlined processing, provider number assignments, and staff training for efficient NHF claims handling. The NHF Card Programme plays a pivotal role in supporting Jamaicans with chronic illnesses by subsidizing medications, supplies, and diagnostic tests. Regular pap smears are vital for cervical cancer prevention, PSA tests aid in early prostate cancer detection, and HbA1c testing is essential for diabetes management—a prevalent chronic condition in Jamaica. With over 50 collection centers and ISO 15189 accreditation, Biomedical is well-equipped to improve healthcare access across diverse communities. Christian highlighted that this partnership with the NHF marks a significant step toward equitable access to diagnostic services, ensuring that ‘geography and finances never stand between Jamaicans and the healthcare they need.’
Biomedical now accepts NHF cards for key cancer and diabetes tests at all locations
